FLT4 anticorps (AA 30-326)
Aperçu rapide pour FLT4 anticorps (AA 30-326) (ABIN2384624)
Antigène
Voir toutes FLT4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 30-326
-
Séquence
- MGHHHHHHSG S-PTLNITEDSY V IDTGDSLSIS CRGQHPLEWT WPGAQEVLTT GGKDSEDTRV VHDCEGTEAR PYCKVLLLAQ THANNTGSYH CYYKYIKARI EGTTAASTYV FVRDFKHPFI NKPDTLLVNR KDSMWVPCLV SIPGLNITLR SQSSALHPDG QEVLWDDRRG MRVPTQLLRD ALYLQCETTW GDQNFLSNLF VVHITGNELY DIQLYPKKSM ELLVGEKLVL NCTVWAEFDS GVTFDWDYPG KQAERAKWVP ERRSQQTHTE LSSILTIHNV SQNDLGPYVC EANNGIQRFR ESTEVI
-
Réactivité croisée
- Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Mo
-
Attributs du produit
- Vascular Endothelial Growth Factor Receptor 3 (VEGFR3, FLT41, FLT4, PCL, Fms-Related Tyrosine Kinase 4)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- VEGFR3 (Pro30~Ile326), MGHHHHHHSGS-P TLNITEDSYV IDTGDSLSIS CRGQHPLEWT WPGAQEVLTT GGKDSEDTRV VHDCEGTEAR PYCKVLLLAQ THANNTGSYH CYYKYIKARI EGTTAASTYV FVRDFKHPFI NKPDTLLVNR KDSMWVPCLV SIPGLNITLR SQSSALHPDG QEVLWDDRRG MRVPTQLLRD ALYLQCETTW GDQNFLSNLF VVHITGNELY DIQLYPKKSM ELLVGEKLVL NCTVWAEFDS GVTFDWDYPG KQAERAKWVP ERRSQQTHTE LSSILTIHNV SQNDLGPYVC EANNGIQRFR ESTEVI
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.05 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Autre désignation
- Vascular Endothelial Growth Factor Receptor 3
-
Pathways
- Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Antigène
-